Guangzhou Wondfo BiotechLtd Balance Sheet Health
Financial Health criteria checks 5/6
Guangzhou Wondfo BiotechLtd has a total shareholder equity of CN¥5.6B and total debt of CN¥564.0M, which brings its debt-to-equity ratio to 10.1%. Its total assets and total liabilities are CN¥6.8B and CN¥1.2B respectively. Guangzhou Wondfo BiotechLtd's EBIT is CN¥507.8M making its interest coverage ratio -96.7. It has cash and short-term investments of CN¥2.1B.
Key information
10.1%
Debt to equity ratio
CN¥564.03m
Debt
| Interest coverage ratio | -96.7x |
| Cash | CN¥2.11b |
| Equity | CN¥5.57b |
| Total liabilities | CN¥1.18b |
| Total assets | CN¥6.75b |
Recent financial health updates
No updates
Recent updates
Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture
Nov 18
Guangzhou Wondfo BiotechLtd's (SZSE:300482) Shareholders May Want To Dig Deeper Than Statutory Profit
Nov 01Cautious Investors Not Rewarding Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Performance Completely
Sep 06Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture
Jul 27Guangzhou Wondfo BiotechLtd's (SZSE:300482) Solid Earnings May Rest On Weak Foundations
Apr 29A Piece Of The Puzzle Missing From Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Share Price
Mar 27There Are Reasons To Feel Uneasy About Guangzhou Wondfo BiotechLtd's (SZSE:300482) Returns On Capital
Feb 29Financial Position Analysis
Short Term Liabilities: 300482's short term assets (CN¥3.8B) exceed its short term liabilities (CN¥504.8M).
Long Term Liabilities: 300482's short term assets (CN¥3.8B) exceed its long term liabilities (CN¥678.7M).
Debt to Equity History and Analysis
Debt Level: 300482 has more cash than its total debt.
Reducing Debt: 300482's debt to equity ratio has increased from 2.3% to 10.1% over the past 5 years.
Debt Coverage: 300482's debt is well covered by operating cash flow (95.4%).
Interest Coverage: 300482 earns more interest than it pays, so coverage of interest payments is not a concern.